Post-COVID syndrome: pulmonary complications

Turk J Med Sci. 2021 Dec 17;51(SI-1):3359-3371. doi: 10.3906/sag-2106-238.


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people worlwide and caused a pandemic that is still ongoing. The virus can cause a disease named as COVID-19, which is composed of multi systemic manifestations with a pulmonary system predominance. As the time passes, we are dealing more and more with a wide variety of effects and complications of the disease in survivors as far as with concerns about the clinical outcome and the timeline of symptoms in different patients. Since the lungs are the most involved organs and the post-COVID prolonged and persistent effects are mainly related to the pulmonary system, it is crucial to define and predict the outcome and to determine the individuals that can progress to fibrosis and loss of function of lungs. This review summarizes the current literature regarding the pulmonary complications in post-COVID syndrome and the management of these conditions.

Keywords: pulmonary complications; Post-COVID.

Publication types

  • Review

MeSH terms

  • COVID-19 / complications*
  • COVID-19 / epidemiology
  • COVID-19 / therapy
  • Fibrosis*
  • Humans
  • Lung / physiopathology*
  • Pandemics
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome / complications*
  • Syndrome